Alpha 2.0
Login Register
» Authors » Huan-Gang Jiang

Huan-Gang Jiang

Explore the profile of Huan-Gang Jiang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 42
Followers 0
Related Specialties
Oncology
General Medicine
Biology
Top 10 Co-Authors
Fu-Xiang Zhou
Wen-Bo Wang
Yun-Feng Zhou
Lei Yang
Cong-Hua Xie
Ya-Hua Zhong
Liu Hu
Jing Dai
Gang Chen
Lin-Zhou Zhang
Published In
Asian Pac J Cancer Prev
Clin Nutr
Nat Commun
PLoS One
Cancer Immunol Res
Affiliations
Soon will be listed here.
Recent Articles
1.
PD-1/CD80 small extracellular vesicles from immunocytes induce cold tumours featured with enhanced adaptive immunosuppression
Zhang L, Yang J, Chen G, Xie Q, Fu Q, Xia H, et al.
Nat Commun . 2024 May; 15(1):3884. PMID: 38719909
Only a minority of cancer patients benefit from immune checkpoint blockade therapy. Sophisticated cross-talk among different immune checkpoint pathways as well as interaction pattern of immune checkpoint molecules carried on...
2.
Therapy-induced senescent tumor cell-derived extracellular vesicles promote colorectal cancer progression through SERPINE1-mediated NF-κB p65 nuclear translocation
Zhang D, Zhang J, Xu H, Chen X, Gao Y, Jiang H, et al.
Mol Cancer . 2024 Apr; 23(1):70. PMID: 38576002
Background: Cellular senescence frequently occurs during anti-cancer treatment, and persistent senescent tumor cells (STCs) unfavorably promote tumor progression through paracrine secretion of the senescence-associated secretory phenotype (SASP). Extracellular vesicles (EVs)...
3.
HRS Regulates Small Extracellular Vesicle PD-L1 Secretion and Is Associated with Anti-PD-1 Treatment Efficacy
Xiao B, Wang X, Xia H, Zhang L, Wang K, Chen Z, et al.
Cancer Immunol Res . 2022 Dec; 11(2):228-240. PMID: 36484721
PD-L1 localized to immunosuppressive small extracellular vesicles (sEV PD-L1) contributes to tumor progression and is associated with resistance to immune-checkpoint blockade (ICB) therapy. Here, by establishing a screening strategy with...
4.
Predictive value of pancreatic dose-volume metrics on sarcopenia rate in gastric cancer patients treated with adjuvant chemoradiotherapy
Li Y, Wang W, Jiang H, Dai J, Xia L, Chen J, et al.
Clin Nutr . 2018 Aug; 38(4):1713-1720. PMID: 30122263
Objective: To evaluate the relationship of sarcopenia with the pancreatic dose-volume histogram (DVH) in gastric cancer patients treated with adjuvant chemoradiotherapy (CRT) after radical gastrectomy. Methods: A retrospective study was...
5.
Prognostic value of mitochondrial DNA content and G10398A polymorphism in non-small cell lung cancer
Xu H, He W, Jiang H, Zhao H, Peng X, Wei Y, et al.
Oncol Rep . 2013 Oct; 30(6):3006-12. PMID: 24101028
Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer-related mortality worldwide. Mitochondrial dysfunction has been postulated to render cancer cells resistant to apoptosis based on the...
6.
The MPO-463G>A polymorphism and lung cancer risk: a meta-analysis based on 22 case-control studies
Yang J, Wang W, Yang X, Yang L, Ren L, Zhou F, et al.
PLoS One . 2013 Jul; 8(6):e65778. PMID: 23840365
Background: Myeloperoxidase (MPO) is an endogenous oxidant enzyme that produces reactive oxygen species (ROS) and may be involved in lung carcinogenesis. The MPO-463G>A polymorphism influences MPO transcription and has been...
7.
Suppression of Ku80 correlates with radiosensitivity and telomere shortening in the U2OS telomerase-negative osteosarcoma cell line
Hu L, Wu Q, Wang W, Jiang H, Yang L, Liu Y, et al.
Asian Pac J Cancer Prev . 2013 Apr; 14(2):795-9. PMID: 23621240
Ku70/80 heterodimer is a central element in the nonhomologous end joining (NHEJ) DNA repair pathway, Ku80 playing a key role in regulating the multiple functions of Ku proteins. It has...